Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons

Neurobiology of Aging

Volumn 28, Issue 3, 2007, Pages 371-376

  Ghidoni, Roberta ^a   Benussi, Luisa ^a   Paterlini, Anna ^a   Missale, Cristina ^b   Usardi, Alessia ^a   Rossi, Rossana ^a   Barbiero, Laura ^a   Spano, PierFranco ^b   Binetti, Giuliano ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b Department of Biomedical Sciences and Biotechnology   (Italy)

Author keywords

Cysteine protease; Familial Alzheimer disease; Glycosylated cystatin C; Mutation; Presenilin 2; Protein secretion

Indexed keywords

CYSTATIN C; PRESENILIN 2;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; GENE MUTATION; MOUSE; NERVE CELL; NERVE REGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; WESTERN BLOTTING;

ANIMALS; ARGININE; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYSTATINS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOLEUCINE; METHIONINE; MICE; MICROSCOPY, CONFOCAL; MUTATION; NEURONS; PRESENILIN-2; PROTEIN TRANSPORT; TAU PROTEINS; THREONINE; TRANSFECTION; TUBULIN;

EID: 33846574690     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.01.007     Document Type: Article

References (25)

1. Babiloni C., Benussi L., Binetti G., Bosco P., Busonero G., Cesaretti S., et al. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study. Neuroimage 29 (2006) 948-964
2. Benussi L., Alberici A., Mayhaus M., Langer U., Ghidoni R., Mazzoli F., et al. Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosis. Exp Cell Res 269 2 (2001) 256-265
3. Benussi L., Ghidoni R., Steinhoff T., Alberici A., Villa A., Mazzoli F., et al. Alzheimer disease-associated cystatin C variant undergoes impaired secretion. Neurobiol Dis 13 1 (2003) 15-21
4. Benussi L., Ghidoni R., Paterlini A., Nicosia F., Alberici A.C., Signorini S., et al. Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation. Exp Cell Res 308 1 (2005) 78-84
5. Binetti G., Signorini S., Squitti R., Alberici A., Benussi L., Cassetta E., et al. Atypical dementia associated to a novel presenilin-2 mutation. Ann Neurol 54 6 (2003) 832-836
6. Crawford F.C., Freeman M.J., Schinka J.A., Abdullah L.I., Gold M., Hartman R., et al. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology 55 6 (2000) 763-768
7. Cruts M., van Duijin C.M., Backhovens H., Van den Broeck M., Wehnert A., Serneels S., et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 7 1 (1998) 43-51
8. Deng A., Irizarry M.C., Nitsch R.M., Growdon J.H., and Rebeck G.W. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J Pathol 159 3 (2001) 1061-1068
9. Finckh U., Alberici A., Antoniazzi M., Benussi L., Fedi V., Giannini C., et al. Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I. Neurology 54 10 (2000) 2006-2008
10. Finckh U., von der Kammer H., Velden J., Michel T., Andresen B., Deng A., et al. Genetic Association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol 57 11 (2000) 1579-1583
11. Giacomello M., Barbiero L., Zatti G., Squitti R., Binetti G., Pozzan T., et al. Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol Dis 18 3 (2005) 638-648
12. Higuchi M., Lee V.M., and Trojanowski J.Q. Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2 2 (2002) 131-150
13. Kempermann G., Kuhn H.G., and Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 386 6624 (1997) 493-495
14. Lee V.M., Daughenbaugh R., and Trojanowski J.Q. Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol Aging 15 (1994) S87-S89
15. Levy E., Sastre M., Kumar A., Gallo G., Piccardo P., Ghetti B., et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 60 1 (2001) 94-104
16. Lofberg H., and Grubb A.O. Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 39 7 (1979) 619-626
17. Palmer T.D., Schwartz P.H., Taupin P., Kaspar B., Stein S.A., and Gage F.H. Cell culture. Progenitor cells from human brain after death. Nature 411 6833 (2001) 42-43
18. Paraoan L., Ratnayaka A., Spiller D.G., Hiscott P., White M.R., and Grierson I. Unexpected intracellular localization of the AMD-associated cystatin C variant. Traffic 5 11 (2004) 884-895
19. Pigino G., Morfini G., Pelsman A., Mattson M.P., Brady S.T., and Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci 23 11 (2003) 4499-4508
20. Roy S., Zhang B., Lee V.M., and Trojanowski J.Q. Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol (Berl) 109 1 (2005) 5-13
21. Sastre M., Calero M., Pawlik M., Mathews P.M., Kumar A., Danilov V., et al. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging 25 8 (2004) 1033-1043
22. Takeda K., Araki W., and Tabira T. Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur J Neurosci 19 2 (2004) 258-264
23. Taupin P., Ray J., Fischer W.H., Suhr S.T., Hakansson K., Grubb A., et al. FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 28 2 (2000) 385-397
24. Tennant J.R. Evaluations of the trypan blue technique for determination of cell viability. Transplantation 12 (1964) 685-694
25. Zatti G., Ghidoni R., Barbiero L., Binetti G., Pozzan T., Fasolato C., et al. The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores. Neurobiol Dis 15 2 (2004) 269-278